Stay updated with breaking news from Primrose Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...
Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 ...
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine DevelopmentThe companies will leverage their combined experience in the development of conjugate vaccines for their clients Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravac...
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.
Conference Call and Webcast at 8:30 a.m. Eastern Time Today ...